Effiris: A secondary pharmacology model suite powered by privacy-preserving data sharing
Artificial Intelligence (AI) has become a powerful force within the pharmaceutical industry, catalysed by the challenging lengthy and costly drug development process. To maximize the impact of AI, it is critical to have access to enough good quality data to allow machine learning algorithms to extract relevant knowledge and produce valuable models. Despite the availability […]
Effiris: A secondary pharmacology model suite powered by privacy-preserving data sharing Read More »